Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31896 total
Barclays analyst Manav Patnaik cut his price target on FICO from $1,700 to $935 today, keeping a Buy rating. That is a drop of nearly $765 per share. The move stands out as the sharpest target reduction in today's…
Bill Gates filed a string of purchases in RSG worth roughly $492 million in total, spread across 28 transactions between August 24 and September 2. The filings, which landed in early September, show Gates buying…
Short sellers stepped up pressure on several names this week, with MMED and LCID seeing the sharpest moves among stocks with meaningful market caps. MiniMed Group short interest jumped to 74.5% of free float, up from…
ImmunityBio ends the week with its two most persistent tensions unchanged: a short base that refuses to budge and a small analyst community that keeps its buy ratings firmly in place, with a November earnings date now…
DNP heads into the final day of September with its short score declining steadily and borrow conditions loosening, a combination that paints a less hostile picture for the Warsaw-listed grocer than the data suggested…
JSW has settled into a narrow range with no fresh catalyst to break it, and the data from the past week maps that stagnation precisely. The price action says it all. The stock closed Tuesday at PLN 31.70, a 0.6% gain…
CDR has spent the past week drifting quietly higher, up 0.5% on the week and 1.4% on Tuesday alone to close at PLN 248.70, while the market around it sends mixed signals that are worth unpacking before the November 24…
lululemon athletica is closing out September with short sellers at their most committed in years, the stock down nearly 20% over the past month, and the Street still debating how low the floor is. Short interest has…
Roland Corporation ends September having shed 2.6% over the month to JPY 3,675, a steady, unremarkable decline that leaves the musical instrument maker drifting into its November 6 earnings date with little in the data…
Modivo reports this morning with an almost fully depleted lending pool, a short position covering more than a fifth of the float, and a track record of sharp post-earnings moves in both directions. The borrow market is…
Electra Therapeutics arrived on the public markets last week with an unusually active register: a 13D activist filing from its largest shareholder, $20 million in disclosed open-market buying at the IPO price, and a…
Securitize Corp. enters the final days of September with its lending market pulling back from extremes while short positioning stays stubbornly elevated, a split that leaves the stock trading at $15.84 after a 22%…
Robostrategy, Inc. is a small, lightly covered Nasdaq name where the most interesting tension this week is a divergence: borrowing costs have fallen sharply from their summer peaks, yet options positioning has shifted…
The Elmet Group Co. heads into its October 19 earnings date with short interest nearly doubling over the past month and borrow availability shrinking fast. The borrow market tells the most charged story this week.…
TRAX enters the final quarter of 2026 with a striking disconnect: the Street is aggressively initiating coverage with buy ratings and targets well above the current price, yet short interest has climbed sharply and the…
Kailera Therapeutics has spent September in freefall, and the data heading into October shows bears sitting firmly in control with the next earnings catalyst still six weeks away. The most striking feature of the week…
Solstice Advanced Materials heads into October with a striking divergence: short sellers are retreating rapidly while options traders have swung to their most bullish posture in months, even as the stock itself…
Fermi Inc. heads into October with short sellers accelerating their bets against a stock already down 17% on the week, while an activist on the register and a deeply discounted price tag relative to analyst targets…
The tension that defined the XRP Bitwise XRP ETF a week ago has largely unwound: the shorts that piled in during late September have been covering rapidly, even as the fund itself has given back some of its recent…
ARX closes out September in an unusual standoff: every analyst on the Street is at Hold or below, yet options traders remain among the most bullishly positioned they have been all year. The Street's direction of travel…
